Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Watt

Showing results (371-380 of 380) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 380 results.
Cancer Discovery|October 6, 2025
Correction: INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid TumorsCatherine Dietrich, Alec Trub, Antonio Ahn, et al.
Cancer Discovery|December 4, 2023
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid TumorsCatherine Dietrich, Alec Trub, Antonio Ahn, et al.
Cancer Cell|March 16, 2016
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 InhibitorsShom Goel, Qi Wang, April C Watt, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment EffectsPeter D Inskip, Alice J Sigurdson, Lene Veiga, et al.
Nature|August 17, 2017
CDK4/6 inhibition triggers anti-tumour immunityShom Goel, Molly J DeCristo, April C Watt, et al.
Blood|August 3, 2007
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alphaSteffen Koschmieder, Francesco D'Alò, Hanna Radomska, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
British Journal of Cancer|February 20, 2008
Prospective surveillance of women with a family history of breast cancer: auditing the risk thresholdE Anderson, J Berg, R Black, et al.
Contemporary Clinical Trials|August 30, 2019
Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE): ProtocolKirk I Erickson, George A Grove, Jeffrey M Burns, et al.
Nature Cancer|May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C Watt, Paloma Cejas, Molly J DeCristo, et al.
Pageof 38

Showing results (371-380 of 380) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 380 results.
Cancer Discovery|October 6, 2025
Correction: INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid TumorsCatherine Dietrich, Alec Trub, Antonio Ahn, et al.
Cancer Discovery|December 4, 2023
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid TumorsCatherine Dietrich, Alec Trub, Antonio Ahn, et al.
Cancer Cell|March 16, 2016
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 InhibitorsShom Goel, Qi Wang, April C Watt, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment EffectsPeter D Inskip, Alice J Sigurdson, Lene Veiga, et al.
Nature|August 17, 2017
CDK4/6 inhibition triggers anti-tumour immunityShom Goel, Molly J DeCristo, April C Watt, et al.
Blood|August 3, 2007
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alphaSteffen Koschmieder, Francesco D'Alò, Hanna Radomska, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
British Journal of Cancer|February 20, 2008
Prospective surveillance of women with a family history of breast cancer: auditing the risk thresholdE Anderson, J Berg, R Black, et al.
Contemporary Clinical Trials|August 30, 2019
Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE): ProtocolKirk I Erickson, George A Grove, Jeffrey M Burns, et al.
Nature Cancer|May 17, 2021
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C Watt, Paloma Cejas, Molly J DeCristo, et al.
Pageof 38